About Core Biogenesis
Core Biogenesis is a company based in Paris (France) founded in 2020 by Chouaib Meziadi, Maurice Moloney, and Alexandre Reeber.. Core Biogenesis has raised $14.12 million across 3 funding rounds from investors including Plug and Play Tech Center, XAnge and Blue Horizon. Core Biogenesis offers products and services including Recombinant Protein Platform and Peptide Targeting Technology. Core Biogenesis operates in a competitive market with competitors including Qkine, Future Fields, KAICO, AntiCancer and Protera, among others.
- Headquarter Paris, France
- Founders Chouaib Meziadi, Maurice Moloney, Alexandre Reeber
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Core Biogenesis
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$14.12 M (USD)
in 3 rounds
-
Latest Funding Round
$10.97 M (USD), Series A
Mar 29, 2022
-
Investors
Plug and Play Tech Center
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Core Biogenesis
Core Biogenesis offers a comprehensive portfolio of products and services, including Recombinant Protein Platform and Peptide Targeting Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for producing high-value proteins using plant biofactories
Technology that targets peptides to plant oleosomes for skincare applications
Unlock access to complete
Funding Insights of Core Biogenesis
Core Biogenesis has successfully raised a total of $14.12M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $10.97 million completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $11.0M
-
First Round
First Round
(08 Dec 2020)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2022 | Amount | Series A - Core Biogenesis | Valuation | XAnge | |
| Mar, 2022 | Amount | Grant - Core Biogenesis | Valuation |
investors |
|
| Dec, 2020 | Amount | Seed - Core Biogenesis | Valuation | Entrepreneur First , Plug and Play Tech Center |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Core Biogenesis
Core Biogenesis has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include Plug and Play Tech Center, XAnge and Blue Horizon. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund focused on tech companies
|
Founded Year | Domain | Location | |
|
Sustainable food sector ventures are invested in by Blue Horizon.
|
Founded Year | Domain | Location | |
|
Provider of a program turning individuals into funded technology company founders
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Core Biogenesis
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Core Biogenesis
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Core Biogenesis Comparisons
Competitors of Core Biogenesis
Core Biogenesis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Qkine, Future Fields, KAICO, AntiCancer and Protera, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Animal-free growth factors are developed for life science applications.
|
|
| domain | founded_year | HQ Location |
Serum-free bioactive growth factors and recombinant proteins are biomanufactured.
|
|
| domain | founded_year | HQ Location |
Manufacturer of portfolio of proteins and other biological cytokines and enzymes
|
|
| domain | founded_year | HQ Location |
Reagents and models for cancer research are developed and supplied.
|
|
| domain | founded_year | HQ Location |
Protein-based enzyme technologies are developed using deep learning algorithms.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Core Biogenesis
Frequently Asked Questions about Core Biogenesis
When was Core Biogenesis founded?
Core Biogenesis was founded in 2020.
Where is Core Biogenesis located?
Core Biogenesis is headquartered in Paris, France.
Who is the current CEO of Core Biogenesis?
Alexandre Reeber is the current CEO of Core Biogenesis. They have also founded this company.
Is Core Biogenesis a funded company?
Core Biogenesis is a funded company, having raised a total of $14.12M across 3 funding rounds to date. The company's 1st funding round was a Seed of $3.15M, raised on Dec 08, 2020.
What does Core Biogenesis do?
Core Biogenesis was founded in 2020 in Paris, France, within the biotechnology sector. A UBaaS platform is utilized to enable scalable bioproduction of recombinant proteins, with plants employed as biofactories for high-value bioproducts. Human growth factors are included among the outputs. Operations focus on accelerating mass production through this service model, supporting advancements in biomanufacturing.
Who are the top competitors of Core Biogenesis?
Core Biogenesis's top competitors include Future Fields, Qkine and Algenex.
What products or services does Core Biogenesis offer?
Core Biogenesis offers Recombinant Protein Platform and Peptide Targeting Technology.
Who are Core Biogenesis's investors?
Core Biogenesis has 6 investors. Key investors include Plug and Play Tech Center, XAnge, Blue Horizon, Entrepreneur First, and Thia Ventures.